Ellevest Inc’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.02M | Buy |
8,309
+1,212
| +17% | +$160K | 0.12% | 122 |
|
|
2026
Q1 | $989K | Buy |
7,097
+1,271
| +22% | +$178K | 0.14% | 100 |
|
|
2025
Q4 | $715K | Sell |
5,826
-592
| -9% | -$71.9K | 0.1% | 148 |
|
|
2025
Q3 | $712K | Sell |
6,418
-491
| -7% | -$55.8K | 0.1% | 144 |
|
|
2025
Q2 | $766K | Sell |
6,909
-241
| -3% | -$25.6K | 0.12% | 122 |
|
|
2025
Q1 | $801K | Sell |
7,150
-2,049
| -22% | -$211K | 0.05% | 125 |
|
|
2024
Q4 | $850K | Sell |
9,199
-780
| -8% | -$70.2K | 0.05% | 122 |
|
|
2024
Q3 | $837K | Sell |
9,979
-25
| -0.2% | -$1.91K | 0.05% | 130 |
|
|
2024
Q2 | $686K | Sell |
10,004
-649
| -6% | -$43.3K | 0.04% | 152 |
|
|
2024
Q1 | $780K | Sell |
10,653
-89
| -0.8% | -$6.84K | 0.05% | 130 |
|
|
2023
Q4 | $870K | Sell |
10,742
-431
| -4% | -$33.5K | 0.06% | 96 |
|
|
2023
Q3 | $837K | Buy |
11,173
+393
| +4% | +$30.2K | 0.06% | 79 |
|
|
2023
Q2 | $831K | Sell |
10,780
-40
| -0.4% | -$3.19K | 0.06% | 76 |
|
|
2023
Q1 | $898K | Sell |
10,820
-153
| -1% | -$12.7K | 0.07% | 66 |
|
|
2022
Q4 | $942K | Buy |
10,973
+86
| +0.8% | +$6.81K | 0.08% | 61 |
|
|
2022
Q3 | $672K | Buy |
10,887
+4,814
| +79% | +$304K | 0.06% | 69 |
|
|
2022
Q2 | $375K | Sell |
6,073
-455
| -7% | -$28.2K | 0.04% | 147 |
|
|
2022
Q1 | $388K | Buy |
6,528
+930
| +17% | +$59.4K | 0.03% | 178 |
|
|
2021
Q4 | $406K | Buy |
5,598
+252
| +5% | +$17.4K | 0.04% | 149 |
|
|
2021
Q3 | $373K | Buy |
5,346
+955
| +22% | +$67.1K | 0.04% | 145 |
|
|
2021
Q2 | $302K | Buy |
4,391
+204
| +5% | +$13.6K | 0.03% | 166 |
|
|
2021
Q1 | $271K | Buy |
4,187
+1,010
| +32% | +$65.1K | 0.03% | 151 |
|
|
2020
Q4 | $185K | Buy |
3,177
+1,788
| +129% | +$108K | 0.03% | 183 |
|
|
2020
Q3 | $88K | Sell |
1,389
-192
| -12% | -$13.3K | 0.02% | 292 |
|
|
2020
Q2 | $122K | Buy |
1,581
+585
| +59% | +$44.8K | 0.03% | 166 |
|
|
2020
Q1 | $74K | Buy |
996
+310
| +45% | +$21.4K | 0.02% | 172 |
|
|
2019
Q4 | $45K | Buy |
686
+639
| +1,360% | +$41.6K | 0.01% | 212 |
|
|
2019
Q3 | $3K | Buy |
47
+12
| +34% | +$784 | ﹤0.01% | 303 |
|
|
2019
Q2 | $2K | Sell |
35
-60
| -63% | -$3.95K | ﹤0.01% | 342 |
|
|
2019
Q1 | $6K | Buy |
+95
| New | +$6.31K | ﹤0.01% | 222 |
|
Other funds holding GILD
Ellevest Inc's GILD Position: Q2 2026 in Review
Ellevest Inc increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $160K and bringing the position to 8,309 shares worth $1.02M. The position accounts for 0.12% of the portfolio, ranked #122.
Ellevest Inc first reported a position in GILD in Q1 2019 and has held it in 30 quarters since. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Ellevest Inc held 8,309 shares of Gilead Sciences worth $1.02M as of Q2 2026.
- Ellevest Inc bought 1,212 Gilead Sciences shares in Q2 2026, an estimated $160K.
- Gilead Sciences made up 0.12% of Ellevest Inc's portfolio in Q2 2026, its #122 holding.
- Ellevest Inc first reported a position in Gilead Sciences in Q1 2019 and has held it in 30 quarters since.
- 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.